| Ticker Details |
|
Ginkgo Bioworks Holdings, Inc.
|
| IPO Date: |
September 17, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$558.64M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.25 | 4.54%
|
| Avg Daily Range (30 D): |
$0.35 | 3.72%
|
| Avg Daily Range (90 D): |
$0.37 | 3.59%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
4.19M |
| Avg Daily Volume (30 D): |
.88M |
| Avg Daily Volume (90 D): |
.96M |
| Trade Size |
| Avg Trade Size (Sh.): |
131 |
| Avg Trade Size (Sh.) (30 D): |
70 |
| Avg Trade Size (Sh.) (90 D): |
74 |
| Institutional Trades |
| Total Institutional Trades: |
2,273 |
| Avg Institutional Trade: |
$1.77M |
| Avg Institutional Trade (30 D): |
$.9M |
| Avg Institutional Trade (90 D): |
$.98M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.64M |
| Avg Closing Trade (30 D): |
$.85M |
| Avg Closing Trade (90 D): |
$.93M |
| Avg Closing Volume: |
58.23K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-6.18
|
$-1.45
|
$-1.1
|
|
Diluted EPS
|
$-6.18
|
$-1.45
|
$-1.1
|
|
Revenue
|
$180.61M
|
$38.84M
|
$49.6M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-339.55M
|
$-80.76M
|
$-60.3M
|
|
Operating Income / Loss
|
$-348.13M
|
$-90.02M
|
$-65.54M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-504.58M
|
$-94.39M
|
$-104.05M
|
|
PE Ratio
|
|
|
|
|
|
|